Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are ...

A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, like COVID-19 and pneumonia, for several months.

Earlier this month, major U.S. medical groups asked a federal judge to block the administration from implementing new guidance that cuts the number of vaccines routinely recommended for children and ...

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

The co-founders of vaccine maker BioNTech are stepping down to launch a venture focused on next-generation messenger RNA ...

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

A key U.S. federal vaccine advisory ​panel has dropped a push against COVID mRNA ‌vaccines, the Washington Post reported on Wednesday, citing two people familiar with the matter.

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...

Moderna’s Omicron-adapted COVID-19 vaccines appear to reduce the risk of hospitalization and death in adults who are not pregnant or have a weakened immune system, according to a rapid review ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...